BCOR Involvement in Cancer

References

• Huynh KD , FischleW , VerdinE , BardwellVJ. BCOR, a novel corepressor involved in BCL-6 repression. Genes Dev.14(14), 1810–1823 (2000).
   PubMed Web of Science ®Google Scholar
• Blackledge NP , RoseNR , KloseRJ. Targeting polycomb systems to regulate gene expression: modifications to a complex story. Nat. Rev. Mol. Cell Biol.16(11), 643–649 (2015).
   PubMed Web of Science ®Google Scholar
• Junco SE , WangR , GaipaJCet al. Structure of the polycomb group protein PCGF1 in complex with BCOR reveals basis for binding selectivity of PCGF homologs. Structure21(4), 665–671 (2013).
   PubMed Web of Science ®Google Scholar
• Chittock EC , LatwielS , MillerTCR , MüllerCW. Molecular architecture of polycomb repressive complexes. Biochem. Soc. Trans.45(1), 193–205 (2017).
   PubMedGoogle Scholar
• Blackledge NP , FarcasAM , KondoTet al. Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation. Cell157(6), 1445–1459 (2014).
   PubMed Web of Science ®Google Scholar
• Schuettengruber B , BourbonH-M , DiCroce L , CavalliG. Genome regulation by polycomb and trithorax: 70 years and counting. Cell171(1), 34–57 (2017).
   PubMed Web of Science ®Google Scholar
• Rose NR , KingHW , BlackledgeNPet al. RYBP stimulates PRC1 to shape chromatin-based communication between polycomb repressive complexes. Elife5, e18591 (2016). ,
   PubMed Web of Science ®Google Scholar
• van den Boom V , MaatH , GeugienMet al. Non-canonical PRC1.1 targets active genes independent of H3K27me3 and is essential for leukemogenesis. Cell Rep.14(2), 332–346 (2016).
   PubMed Web of Science ®Google Scholar
• Béguelin W , TeaterM , GearhartMDet al. EZH2 and BCL6 cooperate to assemble CBX8–BCOR complex to repress bivalent promoters, mediate germinal center formation and lymphomagenesis. Cancer Cell.30(2), 197–213 (2016).
   PubMed Web of Science ®Google Scholar
• Koh DI , ChoiWI , JeonBN , LeeCE , YunCO , HurMW. A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene. J. Biol. Chem.284(30), 19856–19866 (2009).
   PubMed Web of Science ®Google Scholar
• Lanzuolo C , OrlandoV. Memories from the polycomb group proteins. Annu. Rev. Genet.46(1), 561–589 (2012).
   PubMedGoogle Scholar
• Gearhart MD , CorcoranCM , WamstadJA , BardwellVJ. Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets. Mol. Cell. Biol.26(18), 6880–6889 (2006).
   PubMed Web of Science ®Google Scholar
• Wong SJ , GearhartMD , TaylorABet al. KDM2B recruitment of the polycomb group complex, PRC1.1, requires cooperation between PCGF1 and BCORL1. Structure24(10), 1795–1801 (2016).
   PubMed Web of Science ®Google Scholar
• Gil J , O’LoghlenA. PRC1 complex diversity: where is it taking us?Trends Cell Biol.24(11), 632–641 (2014).
   PubMed Web of Science ®Google Scholar
• Schwartz YB , PirrottaV. A new world of polycombs: unexpected partnerships and emerging functions. Nat. Rev. Genet.14(12), 853–864 (2013).
   PubMed Web of Science ®Google Scholar
• Gao Z , ZhangJ , BonasioRet al. PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol. Cell.45(3), 344–356 (2012).
   PubMed Web of Science ®Google Scholar
• Di Croce L , HelinK. Transcriptional regulation by polycomb group proteins. Nat. Struct. Mol. Biol.20(10), 1147–1155 (2013).
   PubMed Web of Science ®Google Scholar
• Farcas AM , BlackledgeNP , SudberyIet al. KDM2B links the polycomb repressive complex 1 (PRC1) to recognition of CpG islands. Elife1, e00205 (2012).
   PubMed Web of Science ®Google Scholar
• Wang L , BrownJL , CaoR , ZhangY , KassisJA , JonesRS. Hierarchical recruitment of polycomb group silencing complexes. Mol. Cell.14(5), 637–646 (2004).
   PubMed Web of Science ®Google Scholar
• Van der Lugt NM , DomenJ , LindersKet al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the BMI-1 proto-oncogene. Genes Dev.8(7), 757–769 (1994).
   PubMed Web of Science ®Google Scholar
• Akasaka T , KannoM , BallingR , MiezaMA , TaniguchiM , KosekiH. A role for mel-18, a polycomb group-related vertebrate gene, during theanteroposterior specification of the axial skeleton. Development122(5), 1513–1522 (1996).
   PubMed Web of Science ®Google Scholar
• Imagawa E , HigashimotoK , SakaiYet al. Mutations in genes encoding polycomb repressive complex 2 subunits cause Weaver syndrome. Hum. Mutat.38(6), 637–648 (2017).
   PubMed Web of Science ®Google Scholar
• Feberwee HE , FeenstraI , OberoiSet al. Novel BCOR mutations in patients with oculofaciocardiodental (OFCD) syndrome. Clin. Genet.85(2), 194–197 (2014).
   PubMed Web of Science ®Google Scholar
• Ng D , ThakkerN , CorcoranCMet al. Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR. Nat. Genet.36(4), 411–416 (2004).
   PubMed Web of Science ®Google Scholar
• Hedera P , GorskiJL. Oculo-facio-cardio-dental syndrome: skewed X chromosome inactivation in mother and daughter suggest X-linked dominant inheritance. Am. J. Med. Genet. A123A(3), 261–266 (2003).
   PubMed Web of Science ®Google Scholar
• O’Byrne JJ , LaffanE , MurrayDJ , ReardonW. Oculo-facio-cardio-dental syndrome with craniosynostosis, temporal hypertrichosis, and deafness. Am. J. Med. Genet. Part A173(5), 1374–1377 (2017).
   PubMed Web of Science ®Google Scholar
• Sparmann A , van LohuizenM. Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer.6(11), 846–856 (2006).
   PubMed Web of Science ®Google Scholar
• Wamstad JA , CorcoranCM , KeatingAM , BardwellVJ. Role of the transcriptional corepressor BCOR in embryonic stem cell differentiation and early embryonic development. PLoS ONE3(7), e2814 (2008).
   PubMed Web of Science ®Google Scholar
• Wang Z , GearhartMD , LeeY-Wet al. A non-canonical BCOR–PRC1.1 complex represses differentiation programs in human ESCs. Cell Stem Cell.22(2), 235–251.e9 (2018).
   PubMed Web of Science ®Google Scholar
• Gooskens SLM , FurtwänglerR , VujanicGM , DomeJS , GrafN , vanden Heuvel-Eibrink MM. Clear cell sarcoma of the kidney: a review. Eur. J. Cancer.48(14), 2219–2226 (2012).
   PubMed Web of Science ®Google Scholar
• Argani P , PerlmanEJ , BreslowNEet al. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. Am. J. Surg. Pathol.24(1), 4–18 (2000).
   PubMed Web of Science ®Google Scholar
• Boo Y-J , FisherJC , HaleyMJ , CowlesRA , KandelJJ , YamashiroDJ. Vascular characterization of clear cell sarcoma of the kidney in a child: a case report and review. J. Pediatr. Surg.44(10), 2031–2036 (2009).
   PubMed Web of Science ®Google Scholar
• Balarezo FS , JoshiVV. Clear cell sarcoma of the pediatric kidney: detailed description and analysis of variant histologic patterns of a tumor with many faces. Adv. Anat. Pathol.8(2), 98–108 (2001).
   PubMed Web of Science ®Google Scholar
• Ueno-Yokohata H , OkitaH , NakasatoKet al. Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney. Nat. Genet.47(8), 861–863 (2015).
   PubMed Web of Science ®Google Scholar
• Astolfi A , MelchiondaF , PerottiDet al. Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney. Oncotarget6(38), 40934–40939 (2015).
   Google Scholar
• Roy A , KumarV , ZormanBet al. Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney. Nat. Commun.6(1), 8891 (2015).
   PubMedGoogle Scholar
• Karlsson J , ValindA , GisselssonD. BCOR internal tandem duplication and YWHAE–NUTM2B/E fusion are mutually exclusive events in clear cell sarcoma of the kidney. Genes Chromosomes Cancer55(2), 120–123 (2016).
   PubMed Web of Science ®Google Scholar
• Kenny C , BausenweinS , LazaroAet al. Mutually exclusive BCOR internal tandem duplications and YWHAE–NUTM2 fusions in clear cell sarcoma of kidney: not the full story. J. Pathol.238(5), 617–620 (2016).
   PubMed Web of Science ®Google Scholar
• Wong MK , NgCCY , KuickCHet al. Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR–CCNB3 gene fusion. Histopathology72(2), 320–329 (2018).
   PubMed Web of Science ®Google Scholar
• Kao Y-C , SungY-S , ZhangLet al. Recurrent BCOR internal tandem duplication and YWHAE–NUTM2B fusions in soft tissue undifferentiated round cell sarcoma of infancy. Am. J. Surg. Pathol.40(8), 1009–1020 (2016).
   PubMed Web of Science ®Google Scholar
• Chiang S , LeeC-H , StewartCJRet al. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology. Mod. Pathol.30(9), 1251–1261 (2017).
   PubMed Web of Science ®Google Scholar
• Kool M , JonesDTW , JägerNet al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell.25(3), 393–405 (2014).
   PubMed Web of Science ®Google Scholar
• Mirkovic J , CalicchioM , FletcherCD , Perez-AtaydeAR. Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidney. Histopathology67(3), 306–312 (2015).
   PubMed Web of Science ®Google Scholar
• Jet Aw S , HongKuick C , HweeYong Met al. Novel karyotypes and cyclin D1 immunoreactivity in clear cell sarcoma of the kidney. Pediatr. Dev. Pathol.18(4), 297–304 (2015).
   PubMed Web of Science ®Google Scholar
• Antonescu C . Round cell sarcomas beyond Ewing: emerging entities. Histopathology64(1), 26–37 (2014).
   PubMed Web of Science ®Google Scholar
• Pierron G , TirodeF , LucchesiCet al. A new subtype of bone sarcoma defined by BCOR–CCNB3 gene fusion. Nat. Genet.44(4), 461–466 (2012).
   PubMed Web of Science ®Google Scholar
• Cuthbertson DW , CaceresK , HicksJ , FriedmanEM. A cooperative approach to diagnosis of rare diseases: primitive myxoid mesenchymal tumor of infancy. Ann. Clin. Lab. Sci.44(3), 310–316 (2014).
   PubMed Web of Science ®Google Scholar
• Wei S , SiegalGP. Round cell tumors of bone. Adv. Anat. Pathol.21(5), 359–372 (2014).
   PubMed Web of Science ®Google Scholar
• Chang KTE , GoytainA , TuckerTet al. Development and evaluation of a pan-sarcoma fusion gene detection assay using the NanoString nCounter platform. J. Mol. Diagn.20(1), 63–77 (2018).
   PubMed Web of Science ®Google Scholar
• Machado I , YoshidaA , MoralesMGNet al. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, “undifferentiated small round cell tumors”. A clinicopathologic, immunophenotypic and molecular analysis. Ann. Diagn. Pathol.34, 1–12 (2018).
   PubMed Web of Science ®Google Scholar
• Kao Y-C , OwoshoAA , SungY-Set al. BCOR–CCNB3 fusion positive sarcomas: a clinicopathologic and molecular analysis of 36 cases with comparison to morphologic spectrum and clinical behavior of other round cell sarcomas. Am. J. Surg. Pathol.42(5), 604–615 (2018).
   PubMed Web of Science ®Google Scholar
• Santiago T , ClayMR , AllenSJ , OrrBA. Recurrent BCOR internal tandem duplication and BCOR or BCL6 expression distinguish primitive myxoid mesenchymal tumor of infancy from congenital infantile fibrosarcoma. Mod. Pathol.30(6), 884–891 (2017).
   PubMed Web of Science ®Google Scholar
• Yamada Y , KudaM , KohashiKet al. Histological and immunohistochemical characteristics of undifferentiated small round cell sarcomas associated with CIC–DUX4 and BCOR–CCNB3 fusion genes. Virchows Arch.470(4), 373–380 (2017).
   PubMed Web of Science ®Google Scholar
• Machado I , YoshidaA , López-GuerreroJAet al. Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors. Pathol. Res. Pract.213(9), 1048–1053 (2017).
   PubMed Web of Science ®Google Scholar
• Specht K , ZhangL , SungY-Set al. Novel BCOR–MAML3 and ZC3H7B–BCOR gene fusions in undifferentiated small blue round cell sarcomas. Am. J. Surg. Pathol.40(4), 433–442 (2016).
   PubMed Web of Science ®Google Scholar
• Puls F , NiblettA , MarlandGet al. BCOR–CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma. Am. J. Surg. Pathol.38(10), 1307–1318 (2014).
   PubMed Web of Science ®Google Scholar
• Ludwig K , AlaggioR , ZinAet al. BCOR–CCNB3 undifferentiated sarcoma – does immunohistochemistry help in the identification? Pediatr. Dev. Pathol. 20(4), 321–329 (2017).
   PubMed Web of Science ®Google Scholar
• Peters TL , KumarV , PolikepahadSet al. BCOR–CCNB3 fusions are frequent in undifferentiated sarcomas of male children. Mod. Pathol.28(4), 575–586 (2015).
   PubMed Web of Science ®Google Scholar
• Li W-S , LiaoI-C , WenM-C , LanHH-C , YuS-C , HuangH-Y. BCOR–CCNB3-positive soft tissue sarcoma with round-cell and spindle-cell histology: a series of four cases highlighting the pitfall of mimicking poorly differentiated synovial sarcoma. Histopathology69(5), 792–801 (2016).
   PubMed Web of Science ®Google Scholar
• Panagopoulos I , ThorsenJ , GorunovaLet al. Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation. Genes Chromosomes Cancer52(7), 610–618 (2013).
   PubMed Web of Science ®Google Scholar
• Cramer SL , MillerAL , PresseyJGet al. Pediatric anaplastic embryonal rhabdomyosarcoma: targeted therapy guided by genetic analysis and a patient-derived xenograft study. Front. Oncol.7, 327 (2017).
   PubMed Web of Science ®Google Scholar
• Mackintosh C . Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem. J.381(2), 329–342 (2004).
   PubMedGoogle Scholar
• Rakheja D , WeinbergAG , TomlinsonGE , PartridgeK , SchneiderNR. Translocation (10;17)(q22;p13): a recurring translocation in clear cell sarcoma of kidney. Cancer Genet. Cytogenet.154(2), 175–179 (2004).
   PubMedGoogle Scholar
• French CA , MiyoshiI , KubonishiI , GrierHE , Perez-AtaydeAR , FletcherJA. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res.63(2), 304–307 (2003).
   PubMed Web of Science ®Google Scholar
• Hoang LN , AnejaA , ConlonNet al. Novel high-grade endometrial stromal sarcoma. Am. J. Surg. Pathol.41(1), 12–24 (2017).
   PubMed Web of Science ®Google Scholar
• Knutson SK , WarholicNM , WigleTJet al. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2. Proc. Natl Acad. Sci. USA110(19), 7922–7927 (2013).
   PubMed Web of Science ®Google Scholar
• Bantignies F , CavalliG. Polycomb group proteins: repression in 3D. Trends Genet.27(11), 454–464 (2011).
   PubMed Web of Science ®Google Scholar
• Kalb R , LatwielS , BaymazHIet al. Histone H2A monoubiquitination promotes histone H3 methylation in polycomb repression. Nat. Struct. Mol. Biol.21(6), 569–571 (2014).
   PubMed Web of Science ®Google Scholar
• Kao Y-C , SungY-S , ZhangLet al. BCOR overexpression is a highly sensitive marker in round cell sarcomas with BCOR genetic abnormalities. Am. J. Surg. Pathol.40(12), 1670–1678 (2016).
   PubMed Web of Science ®Google Scholar
• Mariño-Enriquez A , LauriaA , PrzybylJet al. BCOR internal tandem duplication in high-grade uterine sarcomas. Am. J. Surg. Pathol.42(3), 335–341 (2018).
   PubMed Web of Science ®Google Scholar
• Louis DN , PerryA , ReifenbergerGet al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol.131(6), 803–820 (2016).
   PubMed Web of Science ®Google Scholar
• Hoffman LM , DeWireM , RyallSet al. Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics. Acta Neuropathol. Commun.4(1), 1 (2016).
   PubMedGoogle Scholar
• Mackay A , BurfordA , CarvalhoDet al. Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell32(4), 520–537.e5 (2017).
   PubMed Web of Science ®Google Scholar
• Bale TA , AbedalthagafiM , BiWLet al. Genomic characterization of recurrent high-grade astroblastoma. Cancer Genet.209(7–8), 321–330 (2016).
   PubMed Web of Science ®Google Scholar
• Northcott PA , JonesDTW , KoolMet al. Medulloblastomics: the end of the beginning. Nat. Rev. Cancer.12(12), 818–834 (2012).
   PubMed Web of Science ®Google Scholar
• Morrissy AS , GarziaL , ShihDJHet al. Divergent clonal selection dominates medulloblastoma at recurrence. Nature529(7586), 351–357 (2016).
   PubMed Web of Science ®Google Scholar
• Argani P , KaoY-C , ZhangLet al. Primary renal sarcomas with BCOR–CCNB3 gene fusion: a report of 2 cases showing histologic overlap with clear cell sarcoma of kidney, suggesting further link between BCOR-related sarcomas of the kidney and soft tissues. Am. J. Surg. Pathol.41(12), 1702–1712 (2017).
   PubMed Web of Science ®Google Scholar
• Antonescu CR , SungY-S , ChenC-Let al. Novel ZC3H7B–BCOR, MEAF6–PHF1, and EPC1–PHF1 fusions in ossifying fibromyxoid tumors-molecular characterization shows genetic overlap with endometrial stromal sarcoma. Genes Chromosomes Cancer53(2), 183–193 (2014).
   PubMed Web of Science ®Google Scholar
• Wamstad JA , BardwellVJ. Characterization of BCOR expression in mouse development. Gene Expr. Patterns7(5), 550–557 (2007).
   PubMed Web of Science ®Google Scholar
• McEvoy J , NagahawatteP , FinkelsteinDet al. RB1 gene inactivation by chromothripsis in human retinoblastoma. Oncotarget5(2), 438–450 (2014).
   PubMedGoogle Scholar
• Zhang J , BenaventeCA , McEvoyJet al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature481(7381), 329–334 (2012).
   PubMed Web of Science ®Google Scholar
• Kooi IE , MolBM , MassinkMPGet al. Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes. Sci. Rep.6(1), 25264 (2016).
   Google Scholar
• Haferlach T , NagataY , GrossmannVet al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia28(2), 241–247 (2014).
   PubMed Web of Science ®Google Scholar
• Cao Q , GearhartMD , GerySet al. BCOR regulates myeloid cell proliferation and differentiation. Leukemia30(5), 1155–1165 (2016).
   PubMed Web of Science ®Google Scholar
• Tanaka T , Nakajima-TakagiY , AoyamaKet al. Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies. J. Exp. Med.214(10), 2901–2913 (2017).
   PubMed Web of Science ®Google Scholar
• Lefebure M , TothillRW , KruseEet al. Genomic characterisation of Eμ-Myc mouse lymphomas identifies BCOR as a Myc co-operative tumour-suppressor gene. Nat. Commun.8, 14581 (2017).
   PubMed Web of Science ®Google Scholar
• Abáigar M , RobledoC , BenitoRet al. Chromothripsis is a recurrent genomic abnormality in high-risk myelodysplastic syndromes. PLoS ONE11(10), e0164370 (2016).
   Web of Science ®Google Scholar
• de Rooij JDE , vanden Heuvel-Eibrink MM , HermkensMCHet al. BCOR and BCORL1 mutations in pediatric acute myeloid leukemia. Haematologica100(5), e194–e195 (2015).
   PubMed Web of Science ®Google Scholar
• Terada K , YamaguchiH , UekiTet al. Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis. Genes Chromosomes Cancer57(8), 401–408 (2018).
   PubMed Web of Science ®Google Scholar
• Olsson L , ZettermarkS , BiloglavAet al. The genetic landscape of paediatric de novo acute myeloid leukaemia as defined by single nucleotide polymorphism array and exon sequencing of 100 candidate genes. Br. J. Haematol.174(2), 292–301 (2016).
   PubMed Web of Science ®Google Scholar
• Yoshida K , SanadaM , ShiraishiYet al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature478(7367), 64–69 (2011).
   PubMed Web of Science ®Google Scholar
• Damm F , ChesnaisV , NagataYet al. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders. Blood122(18), 3169–3177 (2013).
   PubMed Web of Science ®Google Scholar
• Montalban-Bravo G , TakahashiK , PatelKet al. Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Oncotarget9(11), 9714–9727 (2018).
   PubMedGoogle Scholar
• Tarlock K , ZhongS , HeYet al. Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling. Oncotarget9(41), 26417–26430 (2018).
   PubMedGoogle Scholar
• Thota S , VinyAD , MakishimaHet al. Genetic alterations of the cohesin complex genes in myeloid malignancies. Blood124(11), 1790–1798 (2014).
   PubMed Web of Science ®Google Scholar
• Yamato G , ShibaN , YoshidaKet al. ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1–RUNX1T1 and associated with a better prognosis. Genes Chromosomes Cancer56(5), 382–393 (2017).
   PubMed Web of Science ®Google Scholar
• Eisfeld A-K , MrózekK , KohlschmidtJet al. The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia. Leukemia31(10), 2211–2218 (2017).
   PubMed Web of Science ®Google Scholar
• Bolli N , ManesN , McKerrellTet al. Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol. Haematologica100(2), 214–222 (2015).
   PubMed Web of Science ®Google Scholar
• Eisfeld A-K , KohlschmidtJ , MrózekKet al. Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL–PTD, DNMT3A, U2AF1, FLT3–ITD and IDH2. Leukemia30(11), 2254–2258 (2016).
   PubMed Web of Science ®Google Scholar
• Herold T , MetzelerKH , VosbergSet al. Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis. Blood124(8), 1304–1311 (2014).
   PubMed Web of Science ®Google Scholar
• Shiba N , YoshidaK , ShiraishiYet al. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia. Br. J. Haematol.175(3), 476–489 (2016).
   PubMed Web of Science ®Google Scholar
• Nazha A , ZarzourA , Al-IssaKet al. The complexity of interpreting genomic data in patients with acute myeloid leukemia. Blood Cancer J.6(12), e510 (2016).
   PubMedGoogle Scholar
• Metzeler KH , HeroldT , Rothenberg-ThurleyMet al. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. Blood128(5), 686–698 (2016).
   PubMed Web of Science ®Google Scholar
• Kihara R , NagataY , KiyoiHet al. Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients. Leukemia28(8), 1586–1595 (2014).
   PubMed Web of Science ®Google Scholar
• Gaidzik VI , TeleanuV , PapaemmanuilEet al. RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features. Leukemia30(11), 2160–2168 (2016).
   PubMed Web of Science ®Google Scholar
• Patel BJ , PrzychodzenB , ThotaSet al. Genomic determinants of chronic myelomonocytic leukemia. Leukemia31(12), 2815–2823 (2017).
   PubMed Web of Science ®Google Scholar
• Grossmann V , TiacciE , HolmesABet al. Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood118(23), 6153–6163 (2011).
   PubMed Web of Science ®Google Scholar
• Puente XS , BeàS , Valdés-MasRet al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature526(7574), 519–524 (2015).
   PubMed Web of Science ®Google Scholar
• Leeksma AC , TaylorJ , WuBet al. Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia. Leukemia33(2), 390–402 (2019).
   PubMed Web of Science ®Google Scholar
• Ogawa S . Clonal hematopoiesis in acquired aplastic anemia. Blood128(3), 337–347 (2016).
   PubMed Web of Science ®Google Scholar
• Marsh JCW , MuftiGJ. Clinical significance of acquired somatic mutations in aplastic anaemia. Int. J. Hematol.104(2), 159–167 (2016).
   PubMed Web of Science ®Google Scholar
• Kulasekararaj AG , JiangJ , SmithAEet al. Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. Blood124(17), 2698–2704 (2014).
   PubMed Web of Science ®Google Scholar
• Landau DA , CarterSL , StojanovPet al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell152(4), 714–726 (2013).
   PubMed Web of Science ®Google Scholar
• López C , BergmannAK , PaulUet al. Genes encoding members of the JAK–STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia. Br. J. Haematol.173(2), 265–273 (2016).
   PubMed Web of Science ®Google Scholar
• Stengel A , KernW , ZengerMet al. Genetic characterization of T-PLL reveals two major biologic subgroups and JAK3 mutations as prognostic marker. Genes Chromosomes Cancer55(1), 82–94 (2016).
   PubMed Web of Science ®Google Scholar
• Kim J-A , HwangB , ParkSNet al. Genomic profile of chronic lymphocytic leukemia in Korea identified by targeted sequencing. PLoS ONE11(12), e0167641 (2016).
   Web of Science ®Google Scholar
• Stengel A , KernW , MeggendorferMet al. Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AML. Leukemia32(2), 295–302 (2018).
   PubMed Web of Science ®Google Scholar
• Lee S , ParkHY , KangSYet al. Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type. Oncotarget6(19), 17764–17776 (2015).
   PubMed Web of Science ®Google Scholar
• Moreira AL , WonHH , McMillanRet al. Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosis. J. Thorac. Oncol.10(2), 373–380 (2015).
   PubMed Web of Science ®Google Scholar
• Morris LGT , ChandramohanR , WestLet al. The molecular landscape of recurrent and metastatic head and neck cancers. JAMA Oncol.3(2), 244 (2017).
   PubMed Web of Science ®Google Scholar
• Petrini I , RajanA , PhamTet al. Whole genome and transcriptome sequencing of a B3 thymoma. PLoS ONE8(4), e60572 (2013).
   Web of Science ®Google Scholar
• Jallades L , BaseggioL , SujobertPet al. Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma. Haematologica102(10), 1758–1766 (2017).
   PubMed Web of Science ®Google Scholar
• Dobashi A , TsuyamaN , AsakaRet al. Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type. Genes Chromosomes Cancer55(5), 460–471 (2016).
   PubMed Web of Science ®Google Scholar
• Alaggio R , NinfoV , RosolenA , CoffinCM. Primitive myxoid mesenchymal tumor of infancy. Am. J. Surg. Pathol.30(3), 388–394 (2006).
   PubMed Web of Science ®Google Scholar
• Cramer SL , LiR , AliS , BradleyJA , KimHK , PresseyJG. Successful treatment of recurrent primitive myxoid mesenchymal tumor of infancy with BCOR internal tandem duplication. J. Natl. Compr. Cancer Netw.15(7), 868–871 (2017).
   PubMed Web of Science ®Google Scholar
• Watson S , PerrinV , GuillemotDet al. Transcriptomic definition of molecular subgroups of small round cell sarcomas. J. Pathol.245(1), 29–40 (2018).
   PubMed Web of Science ®Google Scholar
• Baldauf MC , OrthMF , DallmayerMet al. Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1–ETS targets. Oncotarget9(2), 1587–1601 (2018).
   PubMedGoogle Scholar
• Matsuyama A , ShibaE , UmekitaYet al. Clinicopathologic diversity of undifferentiated sarcoma with BCOR–CCNB3 fusion: analysis of 11 cases with a reappraisal of the utility of immunohistochemistry for BCOR and CCNB3. Am. J. Surg. Pathol.41(12), 1713–1721 (2017).
   PubMed Web of Science ®Google Scholar
• Machado I , NavarroL , PellinAet al. Defining Ewing and Ewing-like small round cell tumors (SRCT): the need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases. Ann. Diagn. Pathol.22, 25–32 (2016).
   PubMed Web of Science ®Google Scholar
• Vitour D , LindenbaumP , VendeP , BeckerMM , PoncetD. RoXaN, a novel cellular protein containing TPR, LD, and zinc finger motifs, forms a ternary complex with eukaryotic initiation factor 4G and rotavirus NSP3. J. Virol.78(8), 3851–3862 (2004).
   PubMed Web of Science ®Google Scholar
• Shern JF , ChenL , ChmieleckiJet al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov.4(2), 216–231 (2014).
   PubMed Web of Science ®Google Scholar
• Seki M , NishimuraR , YoshidaKet al. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma. Nat. Commun.6(1), 7557 (2015).
   PubMedGoogle Scholar
• Lee C-H , NucciMR. Endometrial stromal sarcoma – the new genetic paradigm. Histopathology67(1), 1–19 (2015).
   PubMed Web of Science ®Google Scholar
• Micci F , GorunovaL , AgostiniAet al. Cytogenetic and molecular profile of endometrial stromal sarcoma. Genes Chromosomes Cancer55(11), 834–846 (2016).
   PubMed Web of Science ®Google Scholar
• Lee C-H , OuW-B , Marino-EnriquezAet al. 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma. Proc. Natl Acad. Sci. USA109(3), 929–934 (2012).
   PubMed Web of Science ®Google Scholar
• Punnett HH , HalliganGE , ZaeriN , KarmazinN. Translocation 10;17 in clear cell sarcoma of the kidney. A first report. Cancer Genet. Cytogenet.41(1), 123–128 (1989).
   PubMedGoogle Scholar
• O’Meara E , StackD , LeeC-Het al. Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney. J. Pathol.227(1), 72–80 (2012).
   PubMed Web of Science ®Google Scholar
• Brownlee NA , PerkinsLA , StewartWet al. Recurring translocation (10;17) and deletion (14q) in clear cell sarcoma of the kidney. Arch. Pathol. Lab. Med.131(3), 446–451 (2007).
   PubMed Web of Science ®Google Scholar
• Lewis N , SoslowRA , DelairDFet al. ZC3H7B–BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity. Mod. Pathol.31(4), 674–684 (2018).
   PubMed Web of Science ®Google Scholar
• Sturm D , OrrBA , ToprakUHet al. New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell164(5), 1060–1072 (2016).
   PubMed Web of Science ®Google Scholar
• Jones DTW , JägerN , KoolMet al. Dissecting the genomic complexity underlying medulloblastoma. Nature488(7409), 100–105 (2012).
   PubMed Web of Science ®Google Scholar
• Pugh TJ , WeeraratneSD , ArcherTCet al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature488(7409), 106–110 (2012).
   PubMed Web of Science ®Google Scholar
• Louis DN , OhgakiH , WiestlerODet al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol.114(2), 97–109 (2007).
   PubMed Web of Science ®Google Scholar
• Yoshida Y , NobusawaS , NakataSet al. CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue. Brain Pathol.28(5), 710–720 (2018).
   Web of Science ®Google Scholar
• Cutcliffe C , KerseyD , HuangC-Cet al. Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clin. Cancer Res.11(22), 7986–7994 (2005).
   PubMed Web of Science ®Google Scholar
• Paret C , TheruvathJ , RussoAet al. Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy. Oncotarget7(50), 83378–83391 (2016).
   PubMedGoogle Scholar
• Choe J-Y , YunJY , JeonYKet al. Sonic hedgehog signalling proteins are frequently expressed in retinoblastoma and are associated with aggressive clinicopathological features. J. Clin. Pathol.68(1), 6–11 (2015).
   PubMed Web of Science ®Google Scholar
• Kool M , KorshunovA , RemkeMet al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol.123(4), 473–484 (2012).
   PubMed Web of Science ®Google Scholar
• Yan L , PingN , ZhuMet al. Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification. Haematologica97(11), 1708–1712 (2012).
   PubMed Web of Science ®Google Scholar
• Yamamoto Y , TsuzukiS , TsuzukiM , HandaK , InagumaY , EmiN. BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia. Blood116(20), 4274–4283 (2010).
   PubMed Web of Science ®Google Scholar
• Ichikawa S , IchikawaS , IshikawaI , TakahashiT , FujiwaraT , HarigaeH. Successful treatment of acute promyelocytic leukemia with a t(X;17)(p11.4;q21) and BCOR–RARA fusion gene. Cancer Genet.208(4), 162–163 (2015).
   PubMed Web of Science ®Google Scholar
• Yoshizato T , DumitriuB , HosokawaKet al. Somatic mutations and clonal hematopoiesis in aplastic anemia. N. Engl. J. Med.373(1), 35–47 (2015).
   PubMed Web of Science ®Google Scholar
• Park HS , ParkSN , ImKet al. Telomere length and somatic mutations in correlation with response to immunosuppressive treatment in aplastic anaemia. Br. J. Haematol.178(4), 603–615 (2017).
   PubMed Web of Science ®Google Scholar
• Chahal M , PleasanceE , GrewalJet al. Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making. Mol. Case Stud.4(2), a002626 (2018).
   Google Scholar
• García-Sanz P , TriviñoJC , MotaAet al. Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma. Int. J. Cancer.140(7), 1551–1563 (2017).
   PubMed Web of Science ®Google Scholar
• Zhao S , BelloneS , LopezSet al. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition. Proc. Natl Acad. Sci. USA113(43), 12238–12243 (2016).
   PubMed Web of Science ®Google Scholar